Detection of circulating tumor cells, which are released from primary or metastatic lesions into the bloodstream and are the “seeds” for distant metastatic lesions, has been of interest in cancer research and treatment because these cells can potentially provide information on cancer detection, prognosis, and likelihood of treatment response with minimally invasive methods.
Datar Cancer Genetics, a world leader in non-invasive cancer screening, diagnostics, and precision oncology, today announced that it has appointed Dr. Razelle
Datar Cancer Genetics, a world leader in non-invasive cancer screening and diagnostics, today announced that it had designated Dr. Massimo Cristofanilli, a
Datar Cancer Genetics has announced its collaboration with AVM Labs to offer its innovative, blood-based Trucheck cancer screening solutions across Bahrain.